Online Exclusives

Online Exclusives

FDA to Create a New Office to Evaluate Cutting-Edge Science

The U.S. Food and Drug Administration (FDA) plans to create a new department called the Office of Drug Evaluation Science (ODES) that will standardize...

Judge Blocks Cuts to 340B Drug Pricing Program

As part of an overall effort to lower the price of prescription drugs, the Trump administration instated a policy that reduced payments to hospitals...

FDA Expands Dasatinib’s Approval to Pediatric Ph-Positive ALL

The U.S. Food and Drug Administration (FDA) expanded the approval of dasatinib to include the treatment of pediatric patients (≥1 year of age) with...

Bristol-Myers Squibb to Purchase Celgene

Bristol-Myers Squibb (BMS) agreed to buy Celgene for $74 billion, making it the second-biggest purchase in the pharmaceutical and biotechnology industry. The merged company...

New Year, New Price Hikes

More than 30 pharmaceutical companies rang in the new year by raising prices on their medications, according to an analysis from Rx Savings Solutions....

China First to Approve Oral Drug to Stimulate Erythropoiesis

China’s National Medical Products Administration approved the oral anemia drug roxadustat, well before regulators in the U.S. or Europe have issued decisions. The hypoxia-inducible...

Novartis Defends Price Tag of Its Million-Dollar Gene Therapy

In advance of a key report from the Institute for Clinical and Economic Review (ICER) – a nonprofit that assesses the economic benefits of...

NIH Cutting Ties With Private Research Donors?

In early 2018, the National Institutes of Health (NIH) chose to halt a study that was likely to yield data that cast the alcohol...

Generic Drug Makers Shielded From Liability

By shelving a proposed federal rule to allow generic drug makers to update the warning labels on their medicines, the U.S. Food and Drug...

Congress Passes Sickle Cell Bill, House Combats Medicaid Fraud, and more

The U.S. House of Representatives recently passed several bills that may help lower drug prices, improve care for patients with sickle cell disease (SCD),...
Advertisement

Current Issue

February 2019, Volume 5, Issue 3

This issue features a look at the unique challenges of developing treatments for orphan diseases, more coverage of the 2018 ASH annual meeting, and more.